A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Pfizer
Pfizer
MacroGenics
DualityBio Inc.
Pfizer
Merus B.V.
Cancer Research UK
CellCentric Ltd.
Novartis
Pfizer
AstraZeneca